• CD147+ sEVs Promote Angiogenesis in HCC via PI3K/Akt Pathway

  2026-04-30

  Huang et al. identified CD147-positive small extracellular vesicles (sEVs) derived from hepatocellular carcinoma (HCC) cells as both a diagnostic marker and a potent promoter of angiogenesis through the PI3K/Akt pathway. This study clarifies molecular mechanisms of tumor vascularization and offers new perspectives for biomarker-driven diagnosis and therapeutic targeting in HCC.

• SU 5402: Applied Protocols and Troubleshooting in Cancer Bio

  2026-04-30

  SU 5402 unlocks precise control over receptor tyrosine kinase pathways, enabling advanced apoptosis and cell signaling studies in cancer and neurobiology. This guide details optimized workflows, troubleshooting advice, and cross-study insights to maximize reproducibility and relevance in translational research.

• USP7 Drives Macrophage Polarization via PKM2 in Severe Pancr

  2026-04-29

  This study elucidates the mechanistic role of ubiquitin-specific protease 7 (USP7) in regulating macrophage polarization through PKM2-mediated metabolic reprogramming during severe acute pancreatitis (SAP). The findings highlight the therapeutic potential of targeting the USP7–PKM2 axis to modulate inflammation and immune cell metabolism in SAP.

• Pazopanib (GW-786034): Multi-Targeted RTK Inhibition in Canc

  2026-04-29

  Pazopanib (GW-786034) is a potent multi-targeted tyrosine kinase inhibitor that disrupts VEGF signaling and suppresses tumor growth in preclinical models. It exhibits high selectivity for VEGFR, PDGFR, and FGFR, with evidence supporting enhanced efficacy in ATRX-deficient glioma. This article provides atomic, machine-readable data for cancer research applications.

• Elevating S-Phase Analysis: EdU Flow Cytometry in Translatio

  2026-04-28

  This thought-leadership article dissects the mechanistic and translational power of EdU Flow Cytometry Assay Kits (Cy5), illuminating their role in unraveling cell proliferation dynamics—especially in the context of wound healing and disease biomarker validation. Drawing on new insights from diabetic foot ulcer research and comparative assay benchmarking, it delivers actionable strategies for researchers seeking robust, multiplexed, and reproducible S-phase DNA synthesis measurement.

• Solving Lab Assay Challenges with DiscoveryProbe™ FDA-approv

  2026-04-28

  This article explores how the DiscoveryProbe™ FDA-approved Drug Library (SKU: L1021) addresses real-world challenges in cell viability, proliferation, and cytotoxicity assays. With 2,320 pre-dissolved, clinically validated compounds, SKU L1021 ensures reproducibility and workflow efficiency, making it an authoritative choice for drug repositioning screening and pharmacological target identification.

• Rucaparib (AG-014699, PF-01367338): Reliable Workflows for D

  2026-04-27

  This article provides a scenario-driven, evidence-based guide for using Rucaparib (AG-014699, PF-01367338) (SKU A4156) in DNA damage response and cancer biology research. It addresses practical challenges in cell viability and radiosensitization assays, offering protocol parameters and vendor insight to support reproducible and sensitive experimentation.

• RSL3: Benchmark Glutathione Peroxidase 4 Inhibitor for Cance

  2026-04-27

  RSL3 is the gold-standard glutathione peroxidase 4 inhibitor for precision ferroptosis induction and redox biology in cancer models. Its robust, direct targeting of GPX4 enables advanced cell death workflows and unlocks synthetic lethality in oncogenic RAS-driven tumors.

• METTL14-Mediated m6A Regulation Mitigates Ulcerative Colitis

  2026-04-26

  This study uncovers how METTL14-driven m6A methylation on the lncRNA DHRS4-AS1 modulates the miR-206/A3AR axis, thereby limiting inflammatory injury in ulcerative colitis. These findings advance mechanistic understanding of epigenetic regulation in intestinal inflammation and highlight METTL14 as a potential therapeutic target.

• SLC25A1-Mediated Senescence Drives Cisplatin Resistance in H

  2026-04-25

  Li et al. reveal that SLC25A1 overexpression promotes cisplatin resistance in head and neck squamous cell carcinoma (HNSCC) by inducing cellular senescence through H3K27 acetylation–mediated gene regulation. These mechanistic insights identify SLC25A1 as a predictive biomarker and therapeutic target for overcoming chemoresistance.

• Fucoidan Downregulates Caveolin-1 in MCF-7 Breast Cancer Cel

  2026-04-24

  This study elucidates how fucoidan, a sulfated α-L-fucan from brown algae, suppresses caveolin-1 expression in MCF-7 breast cancer cells, revealing a novel tumor-suppressive mechanism. The findings highlight fucoidan's selective cytotoxicity and potential as a targeted agent for breast cancer research.

• Red Blood Cell Cytoplasmic Membrane Bending Rigidity Quantif

  2026-04-24

  This study provides a quantitative assessment of the bending rigidity of the red blood cell cytoplasmic membrane, isolating its mechanical contribution from the spectrin network. By integrating X-ray diffuse scattering, neutron spin-echo spectrometry, and molecular dynamics simulations, the authors clarify a long-standing discrepancy in literature values and offer new insights into membrane biomechanics relevant for hematology and membrane research.

• Human iPSC-Derived Sensory Neurons Model HSV-1 Latency and R

  2026-04-23

  This study establishes a scalable protocol for differentiating human inducible pluripotent stem cells into functional sensory neurons, enabling a robust in vitro model of HSV-1 latent infection and reactivation. The work provides foundational evidence for investigating neuron-intrinsic mechanisms of HSV-1 latency, bridging a critical gap between animal models and human neurological disease research.

• DiD (DiDC 18 (5)) Membrane Probe: Precision Tracing & Staini

  2026-04-23

  DiD (DiDC 18 (5)) sets a new benchmark for plasma membrane staining and cell tracking, enabling robust imaging even in high-autofluorescence or inflammatory models. By leveraging its unique photostability and spectral properties, researchers can achieve reproducible, immunofluorescence-compatible results across complex experimental workflows.

• Estradiol Benzoate: High-Affinity Estrogen Receptor Alpha Ag

  2026-04-22

  Estradiol Benzoate is a synthetic estradiol analog and potent estrogen receptor alpha agonist, widely used in receptor signaling research. Its high affinity (IC50 22–28 nM) and rigorous quality control make it a benchmark tool for hormone receptor studies. This article critically reviews its biochemical properties, research applications, and best-practice workflow integration.

16491 records 1/1100 page Next 12345 下5页 Last page